top of page

RYBELSUS® TABLET 14MG

Product details

Registration number: SIN16217P

Classification: Prescription Only

Active ingredients: Semaglutide

Strength: 14mg

Dosage form: TABLET

Route: ORAL

Registrant: NOVO NORDISK PHARMA (SINGAPORE) PTE LTD

ATC code: A10BJ06

HSA approval date: 1 June 2021

Manufacturer(s):

  • Novo Nordisk A/S
  • Novo Nordisk A/S (Primary packager and Secondary packager)

Manufacturing country/countries: DENMARK

What are the HSA registration number and classification for RYBELSUS® TABLET 14MG?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN16217P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for RYBELSUS® TABLET 14MG?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Semaglutide

Strength: 14mg

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for RYBELSUS® TABLET 14MG?

According to the HSA dataset updated 7 August 2026:

Dosage form: TABLET

Route: ORAL

Source for this answer

Who is the recorded registrant for RYBELSUS® TABLET 14MG?

According to the HSA dataset updated 7 August 2026:

Registrant: NOVO NORDISK PHARMA (SINGAPORE) PTE LTD

Source for this answer

Which manufacturers and countries are listed for RYBELSUS® TABLET 14MG?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s):

  • Novo Nordisk A/S
  • Novo Nordisk A/S (Primary packager and Secondary packager)

Manufacturing country/countries: DENMARK

Source for this answer

Where can I look up RYBELSUS® TABLET 14MG in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN16217P or the exact product name RYBELSUS® TABLET 14MG. The general register link does not preselect this product.

Source for this answer

What are the source dates for this RYBELSUS® TABLET 14MG record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this RYBELSUS® TABLET 14MG record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN16217P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page